“Why are so many people taking testosterone for an unapproved use?” ask Steven Woloshin and Lisa M. Schwartz, professors of medicine at the Dartmouth Institute for Health Policy and Clinical Practices in a Washington Post opinion piece titled, “Sell a disease to sell a drug.” Woloshin and Schwartz are co-chairs of the steering committee of Preventing Overdiagnosis, an international conference that will be held in September at the National Institutes of Health. While the overprescribing of medication can be seen with many types of medications, from painkillers to antidepressants, Woloship and Schwartz’s column focuses on the overuse of testosterone replacement ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.